Clinical Trials Browser

Unknown × INDUSTRY × Solid Tumor × Clear all

NCT05037149 2024-03-18

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05798026 2024-03-13

A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT06237413 2024-03-06

A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT04984668 2024-02-09

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05490264 2023-12-07

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT06116240 2023-11-03

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT06041035 2023-09-18

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT06015269 2023-08-29

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04965220 2023-08-09

HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05941936 2023-07-12

A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05934539 2023-07-07

ALG.APV-527 First-in-human Study

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05821595 2023-06-27

JYB1907 in Subjects With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05869240 2023-06-06

BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05207787 2023-06-01

Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT03781219 2023-05-31

A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT03364400 2023-05-15

Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04930354 2023-02-16

ECP-1014 Treatment for Patients With Solid Tumor Cancers

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05198752 2022-10-17

A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05528406 2022-09-06

A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT03758664 2022-07-06

Clinical Study of ICP-192 in Solid Tumors Patients

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05228600 2022-05-20

YL-13027 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05369286 2022-05-11

A Study to Evaluate the Safety and Efficacy of Max-40279 and Toripalimab in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05360368 2022-05-05

HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05212987 2022-01-28

Study of FCN-098 in Patients With Advanced Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04679038 2022-01-26

A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT04122339 2022-01-19

MAX-10181 Given Orally to Patients With Advanced Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04183764 2022-01-19

MAX-40279-01 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05196360 2022-01-19

PD-L1

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05046847 2021-12-03

A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04802980 2021-07-28

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04866485 2021-04-29

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04841421 2021-04-12

Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT04673396 2020-12-21

Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04477057 2020-07-20

PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04228406 2020-01-14

Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04151329 2019-11-05

A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT04143789 2019-10-31

Evaluation of AP-002 in Patients With Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT02963168 2019-10-17

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT03757936 2019-05-23

A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination With Avastin Biosimilar (HLX04) in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT03940820 2019-05-07

Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT02414516 2019-03-13

A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT03844438 2019-02-20

A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT03815084 2019-01-30

A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT03815630 2019-01-30

DC-CIK

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT02968485 2019-01-15

Phase I Study of SHR7390 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT03313219 2017-12-12

Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT01806376 2013-03-08

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT01315431 2012-07-24

A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT00881101 2009-04-15

Clinical Study of Liposomal Paclitaxel in Chinese Patients

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT00657176 2008-04-18

An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor